logo
Plus   Neg
Share
Email

Varian To Buy Embolic Bead Asset From Boston Scientific - Quick Facts

Varian (VAR) said it will purchase a portfolio of drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products from Boston Scientific for a purchase price of $90 million. Varian will benefit from the regulatory clearances in more than 35 countries for the acquired assets.

"This acquisition will strengthen our growing position in the high-value interventional oncology segment and is consistent with our long-term strategy to become a global leader in multidisciplinary, integrated cancer solutions," said Dow Wilson, CEO of Varian.

The deal is subject to approval of the U.S. FTC and the closing of the proposed acquisition of BTG plc by Boston Scientific Corp.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Two companies have recalled Wintergreen Essential Oil saying the lack of child resistant packaging as required carries the risks of poisoning children, the U.S. Consumer Product Safety Commission stated. Waldo, Wisconsin - based Capstone Holdings LLC is calling back about 2,935 units of Simply Earth Wintergreen Essential Oil that were manufactured in the United States. The U.S. Food and Drug Administration approved Merck & Co. Inc.'s combination antibiotic Recarbrio for the expanded indication in the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP). The drug had received initial approval in the U.S. in July 2019 to treat patients with complicated urinary tract infections and complicated intra-abdominal infecti Amazon is expanding the aircraft fleet of its air cargo network by leasing 12 additional Boeing 767-300 converted cargo aircraft from Air Transport Services Group Inc. This comes amid increased demand for shipments due to the coronavirus pandemic. These aircraft will join Amazon Air's existing fleet of 70 aircraft to bring its total network to more than 80 aircraft.
Follow RTT